← Leaderboards
Xiang Wang
University Of Colorado
$4,132,736
Attributed
$5,299,385
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $928.5K · FY2012–24$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,299,385 · 6
By mechanism
R33$2,774,780 · 2
R01$1,301,967 · 1
R21$822,929 · 2
R41$399,709 · 1
Top collaborators
- Corrella Detweiler5 shared
- Heide L Ford1 shared
- Rui Zhao1 shared
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadBaseBiochemicalIn VivoDrug KineticsToxic EffectPharmaceutical PreparationsPropertyStructureMonitorAntibioticsPublic Health RelevanceMammalian CellMolecular TargetSystemic InfectionSmall MoleculeAnti-Bacterial AgentsResistanceBacteriaAnalogDesignPathogenScaffoldStructure-Activity Relationship
Grant awards (16)
Preclinical Studies to Develop an Eya2 Tyr Phosphatase Inhibitor as a Novel Medulloblastoma Therapeutic$399,709
R41 · FY2024 · CA
Development of Novel Resistance-Modifying Agents for MRSA$462,000
R33 · FY2020 · AI · contact PI
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals$462,000
R33 · FY2020 · AI
Development of Novel Resistance-Modifying Agents for MRSA$462,000
R33 · FY2019 · AI · contact PI
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals$460,280
R33 · FY2019 · AI
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals$466,500
R33 · FY2018 · AI
Development of Novel Resistance-Modifying Agents for MRSA$462,000
R33 · FY2018 · AI · contact PI
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals$225,203
R21 · FY2017 · AI
Development of Novel Resistance-Modifying Agents for MRSA$225,095
R21 · FY2017 · AI · contact PI
Specific Chemical Probes for Histone Demethylases$261,070
R01 · FY2016 · GM · contact PI
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals$186,369
R21 · FY2016 · AI
Development of Novel Resistance-Modifying Agents for MRSA$186,262
R21 · FY2016 · AI · contact PI
Specific Chemical Probes for Histone Demethylases$261,333
R01 · FY2015 · GM · contact PI
Specific Chemical Probes for Histone Demethylases$261,591
R01 · FY2014 · GM · contact PI
Specific Chemical Probes for Histone Demethylases$252,680
R01 · FY2013 · GM · contact PI
Specific Chemical Probes for Histone Demethylases$265,293
R01 · FY2012 · GM · contact PI